SomaLogic, Inc. (SLGC)
After hours:
Chart Events
Performance Outlook
| Previous Close | 5.37 |
| Open | 5.41 |
| Bid | 4.50 x 1800 |
| Ask | 5.40 x 3100 |
| Day's Range | 5.10 - 5.45 |
| 52 Week Range | 4.20 - 14.72 |
| Volume | |
| Avg. Volume | 1,721,637 |
| Market Cap | 938.476M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.40 |
| Earnings Date | Nov 15, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 15.00 |
- Simply Wall St.
What Type Of Shareholders Own The Most Number of SomaLogic, Inc. (NASDAQ:SLGC) Shares?
The big shareholder groups in SomaLogic, Inc. ( NASDAQ:SLGC ) have power over the company. Large companies usually have...
- GlobeNewswire
SomaLogic Announces License Agreement with OncoHost for the Development of Precision Cancer Diagnostics
BOULDER, Colo. and BINYAMINA, Israel, June 13, 2022 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced it has signed a licensing agreement with OncoHost, a global leader in next-generation precision oncology for personalized cancer therapy. As part of the agreement, OncoHost will license SomaLogic’s SomaScan® Platform to develop proteomics tests for its PROphet® diagnostic system, designed to predict patient response to immunotherapy trea
- GlobeNewswire
SomaLogic Announces June Conference Participation
BOULDER, Colo., June 01, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that the company will be participating in the following conferences. Jefferies Healthcare ConferenceJune 8-9, 2022, in New York 7th Annual MarketsandMarkets Biomarker and Companion Diagnostics ConferenceJoe Gogain, Director, Clinical R&D will present “Bigger data = better data. Detect 7,000 proteins at once with high throughput to optimize biomarker discover” durin
